Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 6Terminated 2Active not recruiting 2Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Nasopharyngeal Carcinoma 4Nasopharyngeal Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Oropharyngeal Neoplasms 2Carcinoma 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Nasopharyngeal Cancinoma (NPC) 1Mouth Neoplasms 1Lymphoma, Follicular 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Glioblastoma 1Esophageal Squamous Cell Carcinoma 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Astrocytoma 1Advanced Glioblastoma 1

Interventions

Magnetic Resonance Spectroscopy 2vorasidenib 1Transurethral Resection of Bladder 1Temozolomide 1Spinal Puncture 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Eflornithine 1Anthropogenic Effects 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Astrocytoma × Radiotherapy, Intensity-Modulated × Clear all
NCT07215910 2025-10-14

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Not yet recruiting
408 enrolled
CNSLymphoid

Astrocytoma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡